The collaboration will put together the MoxiePlex multiplex fluorescence technology with InSituPlex, Vizgen's proprietary sample preparation technique in which a mixture of antibodies are "barcoded" ...

Role of ADAR1 loss in lung cancer on anti-tumor immunity and tumor cell growth via the RIG-I/MDA5-MAVS pathway. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

Findings suggest that slack titin molecules drive muscle disease, potentially through mechanisms shared with other mechanical ...

A new study from Southeast Europe reveals important insights into the prevalence and transmission patterns of four ...

Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced a strategic partnership with Hamamatsu Photonics K.K., a global leader in optical imaging technology. This ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...